Nosca Méréprine (Noscapine Hydrochloride Monohydrate)

Noscapine acts by modulating sigma‑1 receptors in the central nervous system, which dampens the neuronal signaling that initiates the cough reflex. This mechanism provides cough suppression without engaging opioid receptors, thereby minimizing typical opioid‑related adverse effects.

The appropriate dose of Nosca Méréprine is determined by the prescribing healthcare professional based on the patient’s age, weight, severity of cough, and overall clinical condition. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for noscapine in pregnancy and lactation are limited. It is generally advised to avoid use unless the potential benefit justifies the potential risk to the fetus or infant. Healthcare providers should evaluate each case individually.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Nosca Méréprine (noscapine) offers cough suppression without opioid activity, reducing the risk of dependence, respiratory depression, and constipation associated with codeine. However, codeine may provide stronger analgesic effects, which noscapine lacks. Choice of therapy depends on patient-specific factors, including opioid tolerance and safety considerations.

Store Nosca Méréprine at ambient temperature, preferably below 25 °C, in its original container. Protect the product from moisture, direct sunlight, and extreme temperatures to maintain stability. Keep out of reach of children and do not use if the packaging appears damaged.

Nosca Méréprine is taken orally. The tablet or capsule should be swallowed whole with a glass of water, unless the prescriber advises otherwise. It is usually taken with or without food, following the dosing schedule provided by the healthcare professional.

Serious risks, though rare, include severe allergic reactions such as rash, swelling, or anaphylaxis, as well as hepatic enzyme elevations and hematologic abnormalities like neutropenia. Patients should seek immediate medical attention if they experience signs of a serious reaction.

Individuals with a known hypersensitivity to noscapine or any component of the formulation should avoid the product. Caution is also advised for patients with significant liver or kidney impairment, and it is generally contraindicated during pregnancy unless clearly indicated by a physician.